Skip to Main Content

Paper Details

A multi-omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti-PD1 response in solid tumors.
International Journal of Cancer
1
2022
CD8, CD8 T cell, CD8<sup>+</sup>, CD8<sup>+</sup> T cell, PD1, T cell receptor, TCR, anti-PD1, anti-tumor, cancer, expanded TCR clonotypes, human, metastatic melanoma, murine, murine tumor models, nivolumab, patients, single, solid tumors, tumor, tumor and immune subsets, tumor infiltrating lymphocytes

Datasets

Release 1.2